BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 22798444)

  • 1. Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP.
    Bayraktar S; Eileen B; Shariatmadar S; Lian E
    BMJ Case Rep; 2010 Nov; 2010():. PubMed ID: 22798444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.
    Koulova L; Alexandrescu D; Dutcher JP; O'Boyle KP; Eapen S; Wiernik PH
    Am J Hematol; 2005 Jan; 78(1):49-54. PubMed ID: 15609292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.
    Al-Husban N; Al-Kuran O
    J Med Case Rep; 2018 Jun; 12(1):147. PubMed ID: 29855343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Successful treatment of idiopathic acquired refractory thrombotic thrombocytopenic purpura with an association of rituximab-vindesine. Report of one case].
    Ojeda-Uribe M; Brunot A; Issler M
    Rev Med Chil; 2005 Nov; 133(11):1349-54. PubMed ID: 16446859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rituximab as effective therapy in very severe thrombotic thrombocytopenic purpura (TTP)].
    Illner N; Wolf G
    Dtsch Med Wochenschr; 2010 May; 135(3):71-4. PubMed ID: 20077379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases.
    Evans MW; Vaughan LB; Giffi VS; Zimrin AB; Hess JR
    AIDS Patient Care STDS; 2010 Jun; 24(6):349-52. PubMed ID: 20515417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
    Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P;
    Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coexistence of thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in an Asian woman: a case report.
    Ge H; Shi Z; Zheng Z; Zhu Q; Hong L; Zhang Y; Shen J; Deng S
    J Int Med Res; 2022 Mar; 50(3):3000605221085127. PubMed ID: 35352601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab in a child with autoimmune thrombotic thrombocytopenic purpura refractory to plasma exchange.
    Narayanan P; Jayaraman A; Rustagi RS; Mahadevan S; Parameswaran S
    Int J Hematol; 2012 Jul; 96(1):122-4. PubMed ID: 22552883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Lupus Erythematosus Presenting as Refractory Thrombotic Thrombocytopenic Purpura: A Diagnostic and Management Challenge. A Case Report and Concise Review of the Literature.
    Abu-Hishmeh M; Sattar A; Zarlasht F; Ramadan M; Abdel-Rahman A; Hinson S; Hwang C
    Am J Case Rep; 2016 Oct; 17():782-787. PubMed ID: 27777394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.
    Ozdogu H; Boga C; Kizilkilic E; Yeral M; Kozanoglu I; Karatas M
    J Thromb Thrombolysis; 2007 Apr; 23(2):147-50. PubMed ID: 17221322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Rituximab Treatment in Thrombotic Thrombocytopenic Purpura Patients Complicated by Other Autoimmune Disorders: Two Case Reports.
    Watanabe A; Shiseki M; Oishi M; Kobayashi M; Oshima S; Osanai S; Ryuzaki M; Izuka Y; Tanaka N; Ishiyama M; Shinohara A; Kazama H; Hagiwara S; Yoshinaga K; Tanaka J
    Intern Med; 2021 Sep; 60(17):2859-2862. PubMed ID: 33775998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rituximab for treatment of immune thrombocytopenia and thrombotic thrombocytopenic purpura].
    Miyakawa Y
    Rinsho Ketsueki; 2019; 60(5):480-487. PubMed ID: 31168017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
    Chemnitz JM; Uener J; Hallek M; Scheid C
    Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting B cells in severe thrombotic thrombocytopenic purpura--a road to cure?
    Kyttaris VC
    Crit Care Med; 2012 Jan; 40(1):317-8. PubMed ID: 22179358
    [No Abstract]   [Full Text] [Related]  

  • 16. Coexistence of immune thrombocytopenic purpura and idiopathic membranous glomerulonephritis successfully treated with rituximab.
    Alkindi S; Khan S; Riyami D; Farooqi M; Pathare A
    Platelets; 2010; 21(7):575-7. PubMed ID: 20624006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of refractory thrombotic thrombocytopenic purpura associated with systemic lupus erythematosus with combination of plasma exchange and low-dose rituximab.
    Ma W; Bai W; Wu X; Zhao J; Li M; Zeng X
    Lupus; 2020 Dec; 29(14):1961-1967. PubMed ID: 32838618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombotic Thrombocytopenic Purpura Treated with Rituximab Associated with Primary Sjögren's Syndrome and Primary Hypothyroidism.
    Okumura T; Hashimoto K; Aomura D; Kurasawa Y; Hara Y; Fujii K; Masuda T; Sonoda K; Yamaguchi A; Ogawa Y; Kamijo Y
    Intern Med; 2020 Mar; 59(5):715-719. PubMed ID: 31708547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of resistant thrombotic thrombocytopenic purpura with rituximab and cyclophosphamide.
    Stein GY; Zeidman A; Fradin Z; Varon M; Cohen A; Mittelman M
    Int J Hematol; 2004 Jul; 80(1):94-6. PubMed ID: 15293577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics; 2. Rituximab for ITP and TTP].
    Miyakawa Y
    Nihon Naika Gakkai Zasshi; 2014 Jul; 103(7):1654-9. PubMed ID: 25154261
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.